+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

India Digital PCR (dPCR) and Real-Time PCR (qPCR) Market 2019-2025

  • ID: 5124714
  • Report
  • March 2020
  • Region: India
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Co.
  • bioMérieux S.A.
  • Danaher Corp.
  • Eppendorf AG
  • JN Medsys
India Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, by Technology (Quantitative PCR and Digital PCR), by Product (Reagents and Consumables, Instruments, and Software), by Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025.

India digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 11.3% during the forecast period. India is one of the potential markets for dPCR and qPCR particularly due to the significant prevalence of cancer and CVD in the country. According to the International Agency for Research on Cancer (IARC), India recorded 1.2 million new cancer cases in 2018 which makes It one of the major causes of mortality in the country. Poor economic conditions are supporting the number of mortalities caused by cancer. The absence of proper diagnostic centers for the enormous population is also the key contributing factor to the prevalence of cancer in the country.

The government is considering and acting on various initiatives to reduce the incidences of cancer in the country. For instance, the National Cancer Control Program (NCCP) is a public healthcare initiative formed to decrease the number of cancer patients and improving life for them. The program includes the implementation of evidence-based strategies for prevention. The program also supports the patients economically by providing free check-ups and treatment throughout the country. Additionally, the prevalence of CVDs is growing in the country due to sedentary lifestyle. According to WHO, Non-communicable diseases are estimated to account for around 69% of all fatalities in emerging economies such as India, China, Brazil, and others. India has also reported a significant growth in CVDs in the last decade. Improper healthcare and changing lifestyles contribute to the rise of CVDs in the country.

Owing to this, the major players offering dPCR and qPCR products, such as Abbott Laboratories, Siemens AG and other key players have strengthened its business in India. India has favorable regulations for companies that want to set their business in India. Further, the adoption of strategies focused on the Indian healthcare market, MNCs have strengthened their presence in India and address the issue of affordability. These are one of the major factors driving the growth of the market.

Research Methodology

The market study of the India dPCR and qPCR market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. It will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:
  • India dPCR and qPCR Market Research and Analysis, by Technology
  • India dPCR and qPCR Market Research and Analysis, by Product
  • India dPCR and qPCR Market Research and Analysis, by Application

The Report covers:
  • Comprehensive research methodology of the India dPCR and qPCR market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the India dPCR and qPCR market.
  • Insights about market determinants which are stimulating the India dPCR and qPCR market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Co.
  • bioMérieux S.A.
  • Danaher Corp.
  • Eppendorf AG
  • JN Medsys
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. India dPCR and qPCR Market by Technology
5.1.1. Quantitative PCR (qPCR)
5.1.2. Digital PCR (dPCR)
5.2. India dPCR and qPCR Market by Product
5.2.1. Reagents and Consumables
5.2.2. Instruments
5.2.3. Software
5.3. India dPCR and qPCR Market by Application
5.3.1. Research Application
5.3.2. Clinical Application
5.3.3. Forensic Application

6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. Agilent Technologies, Inc.
6.3. Becton, Dickinson and Co.
6.4. bioMérieux S.A.
6.5. Bio-Rad Laboratories, Inc.
6.6. Danaher Corp.
6.7. Eppendorf AG
6.8. JN Medsys
6.9. Merck KGaA
6.10. Siemens AG
6.11. Takara Bio Inc.
6.12. Thermo Fisher Scientific Inc.

LIST OF TABLES
1. INDIA DPCR AND QPCR MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
2. INDIA DPCR AND QPCR MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
3. INDIA DPCR AND QPCR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

LIST OF FIGURES
1. INDIA DPCR AND QPCR MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
2. INDIA DPCR AND QPCR MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
3. INDIA DPCR AND QPCR MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Co.
  • bioMérieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • Eppendorf AG
  • JN Medsys
  • Merck KGaA
  • Siemens AG
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown